Literature DB >> 6958910

Growth of mouse mammary glands after neonatal sex hormone treatment.

Y Tomooka, H A Bern.   

Abstract

Mammary gland growth was examined in female mice immediately and during 1 month after neonatal treatment with sex hormones. BALB/c mice were given daily injections of hormones for the first 5 days after birth. As a criterion of growth, the number of ductal branchings was counted in stained wholemounts of the fourth (inguinal) pair of glands. At day 6, the growth of the glands was significantly inhibited in animals treated with 17 beta-estradiol (E) or diethylstilbestrol (DES); after treatment with progesterone (P) or androgens, no immediate effect was evident. At day 33, neonatal treatment with E stimulated growth, as did neonatal treatment with testosterone (T) or 5 alpha-dihydrotestosterone (5 alpha-DHT); treatment with a high dose of DES inhibited growth. Treatment with P or 5 beta-dihydrotestosterone had no effect. In conclusion, neonatal treatment with sex hormones has two distinct effects on the growth of mouse mammary gland: 1) inhibition by estrogens, observed immediately after treatment, and 2) stimulation by E, T, and 5 alpha-DHT, observed 4 weeks after treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958910

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

Review 1.  Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood.

Authors:  Suzanne E Fenton; Casey Reed; Retha R Newbold
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-10-19       Impact factor: 13.820

Review 2.  Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer.

Authors:  Tessie Paulose; Lucia Speroni; Carlos Sonnenschein; Ana M Soto
Journal:  Reprod Toxicol       Date:  2014-09-30       Impact factor: 3.143

3.  Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance.

Authors:  Jennifer D Cook; Barbara J Davis; Sheng-Li Cai; J Carl Barrett; Claudio J Conti; Cheryl Lyn Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

Review 4.  Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.

Authors:  Ana M Soto; Cathrin Brisken; Cheryl Schaeberle; Carlos Sonnenschein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-05-24       Impact factor: 2.673

Review 5.  Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.

Authors:  Leena Hilakivi-Clarke; Sonia de Assis; Anni Warri
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-08       Impact factor: 2.673

Review 6.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

Review 7.  Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.

Authors:  Ruthann A Rudel; Suzanne E Fenton; Janet M Ackerman; Susan Y Euling; Susan L Makris
Journal:  Environ Health Perspect       Date:  2011-06-22       Impact factor: 9.031

Review 8.  Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters.

Authors:  Leena Hilakivi-Clarke
Journal:  Breast Cancer Res       Date:  2014       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.